首页> 外文期刊>Transplantation Proceedings >Rapid large-scale culturing of microencapsulated hepatocytes: A promising approach for cell-based hepatic support
【24h】

Rapid large-scale culturing of microencapsulated hepatocytes: A promising approach for cell-based hepatic support

机译:微囊化肝细胞的快速大规模培养:一种基于细胞的肝支持的有前途的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction The efficacy of any bioartificial liver device requires both rapid production and proper bioactivity of the cells for the bioreactor. The goal of this study was to observe the effect of spinner speed and cell density on the proliferation of microencapsulated immortalized human hepatocytes (HepLL) and human hepatoma (HepG2) cells. Materials and Methods Alginate-chitosan microcapsulated HepG2 and HepLL cells were randomly divided into 2 groups, and each group was further divided into 8 subgroups according to embedded cell density and spinner speed. The growth, metabolism, and functions of the encapsulated cells in each group were evaluated. Results In each group, the cell number, ammonium removal, albumin synthesis, and diazepam clearance increased significantly with the spinner speed, whereas embedded cell density had no impact. Albumin synthesis, removal of ammonium, and diazepam clearance were significantly higher in the microencapsulated HepLL groups than in HepG2 cells at any time point, without any significant difference in cell numbers. Conclusions Spinner culture significantly promoted microencapsulated HepLL and HepG2 cell bioactivity. Wrapped cells had optimal function on day 10 in rolling culture groups. These data show that HepLL cells would be a promising candidate for cell-based liver support therapy.
机译:简介任何生物人工肝装置的功效都需要生物反应器细胞的快速生产和适当的生物活性。这项研究的目的是观察旋转器速度和细胞密度对微囊化永生化人肝细胞(HepLL)和人肝癌(HepG2)细胞增殖的影响。材料与方法将藻酸盐-壳聚糖微囊化的HepG2和HepLL细胞随机分为2组,并根据包埋的细胞密度和旋转器速度将其进一步分为8个亚组。评价每组中包封细胞的生长,代谢和功能。结果在每组中,细胞数量,去除铵,白蛋白合成和地西epa清除率均随着旋转速度的增加而显着增加,而包埋的细胞密度则没有影响。在任何时间点,微囊化的HepLL组中白蛋白的合成,铵的去除和地西epa的清除率均显着高于HepG2细胞,而细胞数没有任何显着差异。结论旋转培养显着促进微囊化HepLL和HepG2细胞的生物活性。在滚动培养组中,包裹的细胞在第10天具有最佳功能。这些数据表明,HepLL细胞将成为基于细胞的肝支持疗法的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号